Key facts
- This page summarizes Andrew D. Dickinson's Form 4 filing for GILEAD SCIENCES, INC. (GILD).
- 5 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 12 Mar 2026, 16:45.
Andrew D. Dickinson - 10 Mar 2026 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- GILD
- Reported as of
- 10 Mar 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 12 Mar 2026, 16:45:40 UTC
- Prior SEC filing
- 02 Mar 2026
- Next SEC filing
- 17 Mar 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Amy Kim by Power of Attorney for Andrew D. Dickinson
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Andrew D. Dickinson filed Form 4 for GILEAD SCIENCES, INC. (GILD) on 12 Mar 2026.
Change
- Previous filing in this sequence was filed on 02 Mar 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001310204
Primary reporting owner
Dickinson Andrew D
- Relationship
- Chief Financial Officer
- Address
- GILEAD SCIENCES, INC., 333 LAKESIDE DRIVE, FOSTER CITY
- Signature
- /s/ Amy Kim by Power of Attorney for Andrew D. Dickinson
- Signature date
- 12 Mar 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
GILD
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +6,469
- Change %
- +3.6%
- Price
- Shares after
- 185,338
- Date
- 10 Mar 2026
- Ownership
- Direct
- Footnotes
- F1
GILD
transaction
Common Stock
Tax liability
- Transaction value
- Shares
- -3,147
- Change %
- -1.7%
- Price
- $148.56*
- Shares after
- 182,191
- Date
- 10 Mar 2026
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
GILD
transaction
Derivative
Restricted Stock Unit
Options Exercise
- Transaction value
- Shares
- -6,469
- Change %
- -24%
- Price
- Shares after
- 21,057
- Date
- 10 Mar 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 6,469
- Exercise price
- Footnotes
- F1, F2
GILD
transaction
Derivative
Restricted Stock Unit
Award
- Transaction value
- Shares
- +9,590
- Change %
- +46%
- Price
- Shares after
- 30,647
- Date
- 10 Mar 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 9,590
- Exercise price
- Footnotes
- F1, F2
GILD
transaction
Derivative
Non-qualified Stock Option (Right to Buy)
Award
- Transaction value
- Shares
- +35,880
- Change %
- Price
- $0.000000*
- Shares after
- 35,880
- Date
- 10 Mar 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 35,880
- Exercise price
- $148.56
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
Footnote F2
The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
Footnote F3
The stock options have a four-year vesting schedule. 25% vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.